Curcumin conjugates and metallocomplexes as lead compounds for development of anticancer agents - A short review

Current Bioactive Compounds

Volumn 4, Issue 3, 2008, Pages 189-199

  de Fátima, Ângelo ^a   Modolo, Luzia V ^b   Neres, Ana Tereza ^a   Ferreira, Carmen V ^c   de Souza, Ana Carolina S ^c  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b PLANT BIOLOGY DIVISION   (United States)

^c UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Antiproliferative activity; Cancer; Curcumin; Curcumin conjugates and metallocomplexes

Indexed keywords

ANTINEOPLASTIC AGENT; CURCUMIN; CURCUMIN GOLD COMPLEX; CURCUMIN VANADYL COMPLEX; DIGLUTAMOYLCURCUMIN; DIGLYCINOYLCURCUMIN; DIVALINOYLCURCUMIN; IMATINIB; MACROGOL; NONSTEROID ANTIINFLAMMATORY AGENT; UNCLASSIFIED DRUG; VITAMIN;

ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; CANCER INHIBITION; CELL PROLIFERATION; COLON CANCER; CYTOTOXICITY; DRUG BIOAVAILABILITY; DRUG HALF LIFE; DRUG METABOLISM; DRUG POTENCY; DRUG RELEASE; DRUG STRUCTURE; DRUG TARGETING; HUMAN; IC 50; INTESTINE CANCER; METASTASIS INHIBITION; MOUTH CANCER; NONHUMAN; PRIORITY JOURNAL; REVIEW; SKIN CANCER; TUMOR VASCULARIZATION;

EID: 65649109015     PISSN: 15734072     EISSN: None     Source Type: Journal    
DOI: 10.2174/157340708786305934     Document Type: Review

References (124)

1. Tallman, M. S., Gilliland, D. G., Rowe, J. M. (2005) Drug therapy for acute myeloid leukemia. Blood, 106, 1154-1163.
2. Tallman, M. S. (2007) Treatment of relapsed or refractory acute promyelocytic leukemia. Best Pract. Res. Clin. Haematol., 20, 57-65.
3. Newman, D. J., Cragg, G. M., Snader, K. M. (2003) Natural products as sources of new drugs over the period 1981-2002. J. Nat. Prod., 66, 1022-1037.
4. Butler, M. S. (2004) The role of natural product chemistry in drug discovery. J. Nat. Prod., 67, 2141-2153.
5. Butler, M.S. (2005) Natural products to drugs: Natural product derived compounds in clinical trials. Nat. Prod. Rep., 22, 162-195.
6. Lee, K. H. (2004) Current developments in the discovery and design of new drug candidates from plant natural product leads. J. Nat. Prod., 67, 273-283.
7. de Fátima, A., Modolo, L. V., Conegero, L. S., Ferreira, C. V., Pilli, R. A., Ferreira, C. V., Kohn, L. K., de Carvalho, J. E. (2006) Styryl lactones and their derivatives: Biological activities, mechanism of action and potential leads for drug design. Curr. Med. Chem., 13, 3371-3384.
8. de Fátima, A., Modolo, L. V., Sanches, A. C. C., Porto, R. R. (2008) Wound healing agents: The role of natural and non-natural products in drug development. Mini-Rev. Med. Chem., 8, 879-888.
9. Anand, P., Sundaram, C., Jhurani, S., Kunnumakkara, A. B., Aggarwal, B. B. (2008) Curcumin and cancer: An "old-age" disease with an "age-old" solution. Cancer Lett., 267, 133-164.
10. Chattopadhyay, I., Biswas, K., Bandyopadhyay, U., Banerjee, R. K. (2004) Turmeric and curcumin: Biological actions and medicinal applications. Curr. Sci., 87, 44-53.
11. Ligeret, H., Barthelemy, S., Zini, R., Tillement, J. P., Labidalle, S., Morin, D. (2004) Effects of curcumin and curcumin derivatives on mitochondrial permeability transition pore. Free Radic. Biol. Med., 36, 919-929.
12. Ohtsu, H., Xiao, Z., Ishida, J., Nagai, M., Wang, H.K., Itokawa, H., Su, C.Y., Shih, C., Chiang, T., Chang, E., Lee, Y., Tsai, M.Y., Chang, C., Lee, K.H. (2002) Antitumor agents. 217. Curcumin analogues as novel androgen receptor antagonists with potential as anti-prostate cancer agents. J. Med. Chem., 45, 5037-5042.
13. Lin, L., Shi, Q., Su, C. Y., Shih, C. C. Y., Lee, K. H. (2006) Antitumor agents 247. New 4-ethoxycarbonylethyl curcumin analogues as potential antiandrogenic agents. Bioorg. Med. Chem., 14, 2527-2534.
14. Lin, L., Shi, Q., Nyarko, A. K., Bastow, K. F., Wu, C. -C., Su, C. -Y., Shih, C. C. -Y., Lee, K. -H. (2006) Antitumor agents. 250. Design and synthesis of new curcumin analogues as potential antiprostate cancer agents. J. Med. Chem., 49, 3963-3972.
15. Gafner, S., Lee, S. K., Cuendet, M., Barthélémy, S., Vergnes, L., Labidalle, S., Mehta, R. G., Boone, C. W., Pezzuto, J. M. (2004) Biologic evaluation of curcumin and structural derivatives in cancer chemoprevention model systems. Phytochemistry, 65, 2849-2859.
16. Weber, W. M., Hunsaker, L. A., Roybal, C. N., Bobrovnikova-Marjon, E. V., Abcouwer, S. F., Royer, R. E., Deck, L. M., Jagt, D. L. V. (2006) Activation of NF..B is inhibited by curcumin and related enones. Bioorg. Med. Chem., 14, 2450-2461.
17. Shim, J. S., Kim, D. H., Jung, H. J., Kim, J. H., Lim, D., Lee, S. K., Kim, K. W., Ahn, J. W., Yoo, J. S., Rho, J. R., Shin, J., Kwon, H. J. (2002) Hydrazinocurcumin, a novel synthetic curcumin derivative, is a potent inhibitor of endothelial cell proliferation. Bioorg. Med. Chem., 10, 2439-2444.
18. Robinson, T. P., Ehlers, T., Hubbard, R. B., Bai, X., Arbiser, J. L., Goldsmith, D. J., Bowen, J. P. (2003) Design, synthesis, and biological evaluation of angiogenesis inhibitors: Aromatic enone and dienone analogues of curcumin. Bioorg. Med. Chem., 13, 115-117.
19. Araújo, C. A. C., Leon, L. L. (2001) Biological acitivities of Curcuma longa L. Mem. Inst. Oswaldo Cruz, 96, 723-728.
20. Aggarwal, B. B., Kumar, A., Bharti, A. C. (2003) Anticancer potential of curcumin: Preclinical and clinical studies. Anticancer Res., 23, 363-398.
21. Duvoix, A., Blasius, R., Delhalle, S., Schnekenburger, M., Morceau, F., Henry, E., Dicato, M., Diederich, M. (2005) Chemopreventive and therapeutic effects of curcumin. Cancer Lett., 223, 181-190.
22. Maheshwari, R. K., Singh, A. K., Gaddipati, J., Srimal, R. C. (2006) Multiple activities of curcumin: A short review.
23. Shishodia, S., Chaturvedi, M. M., Aggarwal, B. B. (2007) Role of curcumin in cancer therapy. Curr. Probl. Cancer, 31, 243-305.
24. Surh, Y. -J., Chun, K. -S. (2007) In The Molecular Targets and Therapeutic Uses of Curcumin in Health and Disease, Aggarwal, B. B.; Surh, Y.-J., Shishodia, S., Eds.; Springer US, Vol. 595, Chapter 5, p 149-172.
25. Simoni, D., Rizzi, M., Rondanin, R., Baruchello, R., Marchetti, P., Invidiata, F. P., Labbozzetta, M., Poma, P., Carina, V., Notarbartolo, M., Alaimo, A., D'Alessandro, N. (2008) Antitumor effects of curcumin and structurally β-diketone modified analogs on multidrug resistant cancer cells. Bioorg. Med. Chem. Lett., 18, 845-849.
26. Ishida, J., Ohtsu, H., Tachibana, Y., Nakanishi, Y., Bastow, K. F., Nagai, M., Wang, H. -K., Itokawa, H., Lee, K. -H. (2002) Antitumor agents. Part 214: Synthesis and evaluation of curcumin analogues as cytotoxic agents. Bioorg. Med. Chem., 10, 3481-3487.
27. Youssef, D., Nichols, C. E., Cameron, T. S., Balzarini, J., De Clercq, E., Jha A. (2007) Design, synthesis, and cytostatic activity of novel cyclic curcumin analogues. Bioorg. Med. Chem. Lett., 17, 5624-5629.
28. Thompson, K. H., Bohmerle, K., Polishchuk, E., Martins, C., Toleikis, P., Tse, J., Yuen, V., McNeill, J. H., Orvig, C. (2004) Complementary inhibition of synoviocyte, smooth muscle cell or mouse lymphoma cell proliferation by a vanadyl curcumin complex compared to curcumin alone. J. Inorg. Biochem., 98, 2063-2070.
29. Mohammadi, K., Thompson, K. H., Patrick, B. O., Storr, T., Martins, C., Polishchuk, E., Yuen, V. G., McNeill, J. H., Orvig, C. (2005) Synthesis and characterization of dual function vanadyl, gallium and indium curcumin complexes for medicinal applications. J. Inorg. Biochem., 99, 2217-2225.
30. Um, Y.; Cho, S.; Woo, H.B.; Kim, Y.K.; Kim, H.; Ham, J.; Kim, S.-N.; Ahn, C.M.; Lee, S. (2008) Synthesis of curcumin mimics with multidrug resistance reversal activities. Bioorg. Med. Chem., 16, 3608-3615.
31. Pillai, G. R., Srivastava A. S., Hassanein, T. I., Chauhan, D.P., Carrier, E. (2004) Induction of apoptosis in human lung cancer cells by curcumin. Cancer Lett., 208, 163-170.
32. Zhang, J., Qi, H., Wu, C. (2004) Research of anti-proliferation of curcumin on A549 human lung cancer cells and its mechanism. J. Chin. Med. Mat., 27, 923-927.
33. Safavy, A., Raisch, K. P., Mantena, S., Sanford, L. L., Sham, S. W., Krishna, N. R., Bonner, J. A. (2007) Design and development of water-soluble curcumin conjugates as potential anticancer agents. J. Med. Chem., 50, 6284-6288.
34. Pan, M. -H., Chang, W. -L., Lin-Shiau, S. -Y., Ho, C. -T., Lin, J. -K. (2001) Induction of apoptosis by garcinol and curcumin through cytochrome c release and activation of caspases in human leukemia HL-60 cells. J. Agric. Food Chem., 49, 1464-1474.
35. Atsumi, T., Tonosaki, K., Fujisawa, S. (2006) Induction of early apoptosis and ROS-generation activity in human gingival fibroblasts (HGF) and human submandibular gland carcinoma (HSG) cells treated with curcumin. Arch. Oral Biol., 51, 913-921.
36. Shi, M., Cai, Q., Yao, L., Mao, Y., Ming, Y., Ouyang, G. (2006) Antiproliferation and apoptosis induced by curcumin in human ovarian cancer cells. Cell Biol. Inter., 30, 221-226.
37. Bachmeier, B. E., Mohrenz, I. V., Mirisola, V., Schleicher, E., Romeo, F., Höhneke, C., Jochum, M., Nerlich, A. G., Pfeffer, U. (2008) Curcumin downregulates the inflammatory cytokines CXCL1 and -2 in breast cancer cells via NFκB. Carcinogenesis, 29, 779-789.
38. Verma, S. P., Goldin, B. R., Lin, P. S. (1998) The inhibition of the estrogenic effects of pesticides and environmental chemicals by curcumin and isoflavonoids. Environ. Health Perspect., 106, 807-812.
39. Tong, Q. S., Zheng, L. D., Lu, P., Jiang, F. C., Chen, F. M., Zeng, F. Q., Wang, L., Dong, J. H. (2006) Apoptosis-inducing effects of curcumin derivatives in human bladder cancer cells. Anti-cancer Drugs, 17, 279-287.
40. Ohori, H., Yamakoshi, H., Tomizawa, M., Shibuya, M., Kakudo, Y., Takahashi, A., Takahahi, S., Kato, S., Suzuki, T., Ishioka, C., Iwabuchi, Y., Shibata, H. (2006) Synthesis and biological analysis of new curcumin analogues bearing an enhance potential for the medicinal treatment of cancer. Mol. Cancer Ther., 5, 2563-2571.
41. Du, B., Jiang, L., Xia, Q., Zhong, L. (2006) Synergistic inhibitory effects of curcumin and 5-fluorouracil on the growth of the human colon cancer cell line HT-29. Chemotherapy, 52, 23-28.
42. Shi, W., Dolai, S., Rizk, S., Hussai, A., Tariq, H., Averick, S., L'Amoreaux, W., El Idrissi, A., Banerjee, P., Raja, K. (2007) Synthesis of monofunctional curcumin derivatives, clicked curcumin dimer, and a PAMAN dendrimer curcumin conjugate for therapeutic applications. Org. Lett., 9, 5461-5464.
43. Dubey, S. K., Sharma, A. K., Narain, U., Misra, K., Pati, U. (2008) Design, synthesis and characterization of some bioactive conjugates of curcumin with glycine, glutamic acid, valine and demethylenated piperic acid and study of their antimicrobial and antiproliferative properties. Eur. J. Med. Chem. (In press).
44. Kaminaga, Y., Nagatsu, A., Akiyama, T., Sugimoto, N., Yamazaki, T., Maitani, T., Mizukami, H. (2003) Production of unnatural glucosides of curcumin with drastically enhanced water solubility by cell suspension cultures of Catharanthus roseus. FEBS Lett., 555, 311-316.
45. Mohri, K., Watanabe, Y., Yoshida, Y., Satoh, M., Isobe, K., Sugimoto, N., Tsuda, Y. (2003) Synthesis of glycosylcurcuminoids. Chem. Pharm. Bull., 51, 1268-1272.
46. Mishra, S., Narain, U., Mishra, R., Misra, K. (2005) Design, development and synthesis of mixed bioconjugates of piperic acidglycine, curcumin-glycine/alanine and curcumin-glycine-piperic acid and their antibacterial and antifungal properties. Bioorg. Med. Chem., 13, 1477-1486.
47. Suzuki, M., Nakamura, T., Iyoki, S., Fujiwara, A., Watanabe, Y., Mohri, K., Isobe, K., Ono, K., Yano, S. (2005) Elucidation of anti 198 Current Bioactive Compounds 2008, Vol. 4, No. 3 de Fátima et al. allergic activities of curcumin-related compounds with a special reference to their anti-oxidative activities. Biol. Pharm. Bull., 28, 438-1443.
48. Shimoda, K., Hara, T., Hamada, H., Hamada, H. (2007) Synthesis of curcumin β-maltooligosaccharides through biocatalytic glycosylation with Strophanthus gratus cell culture and cyclodextrine glucanotransferase. Tetrahedron Lett., 48, 4029-4032.
49. John, V. D., Krishnankutty, K. (2005) Synthesis, characterization and antitumour activities of some synthetic curcuminoid analogues and their copper complexes. Trans. Metal Chem., 30, 229-233.
50. John, V. D., Krishnankutty, K. (2006) Antitumour activity of synthetic curcuminoid analogues (1,7-diaryl-1,6-heptadiene-3,5-diones) and their copper complexes. App. Organomet. Chem., 20, 477-482.
51. Pucci, D., Bloise, R., Bellusci, A., Bernardini, S., Ghedini, M., Pirillo, S., Valentini, A., Crispini, A. (2007) Curcumin and cyclopalladated complexes: A recipe for bifunctional biomaterials. J. Inorg. Biochem., 101, 1013-1022.
52. Sharma, K. K., Chandra, S., Basu, D. K. (1987) Synthesis and antiarthritic study of a new orally active diferuloyl methane (curcumin) gold complex. Inorg. Chim. Acta, 135, 47-48.
53. Vajragupta, O., Boonchoong, P., Watanabe, H., Tohda, M., Kummasud, N., Sumanont, Y. (2003) Manganese complexes of curcumin and its derivatives: evaluation for the radical scavenging ability and neuroprotective activity. Free Rad. Biol. Med., 35, 1632-1644.
54. Sumanont, Y., Murakami, Y., Tohda, M., Vajragupta, O., Watanabe, H., Matsumoto, K. (2006) Prevention of kainic acidinduced changes in nitric oxide level and neuronal cell damage in the rat hippocampus by manganese complexes of curcumin and diacetylcurcumin. Life Sci., 78, 1884-1891.
55. Sumanont, Y., Murakami, Y., Tohda, M., Vajragupta, O., Watanabe, H., Matsumoto, K. (2007) Effects of manganese complexes of curcumin and diacetylcurcumin on kainic acidinduced neurotoxic responses in the rat hippocampus. Biol. Pharm. Bull., 30, 1732-1739.
56. Dutta, S., Murugkar, A., Gandhe, N., Padhye, S. (2001) Enhanced antioxidant activities of metal conjugates of curcumin derivatives. Metal Based Drugs, 8, 183-188.
57. Barik, A., Mishra, B., Shen, L., Mohan, H., Kadam, R. M., Dutta, S., Zhang, H. Y., Priyadarsini, K. I. (2005) Evaluation of a new copper(II)-curcumin complex as superoxide dismutase mimic and its free radical reactions. Free Radic. Biol. Med., 39, 811-822.
58. Aggarwal, B. B., Sundaram, C., Malani, N., Ichikawa, H. (2007) Curcumin: the Indian solid gold. Adv. Exp. Med. Biol., 595, 1-75.
59. Menon, V. P., Sudheer, A. S. (2007) In The Molecular Targets and Therapeutic Uses of Curcumin in Health and Disease, Aggarwal, B.B.; Surh, Y.-J., Shishodia, S., Eds.; Springer US, Vol. 595, Chapter 3, p 105-125.
60. Wei, Q. Y., Chen, W. F., Zhou, B., Yang, L., Liu, Z. L. (2006) Inhibition of lipid peroxidation and protein oxidation in rat liver mitochondria by curcumin and its analogues. Biochim. Biophys. Acta, 1760, 70-77.
61. Yoshino, M., Haneda, M., Naruse, M., Htay, H. H., Tsubouchi, R., Qiao, S. L., Li, W. H., Murakami, K., Yokochi, T. (2004) Prooxidant activity of curcumin: Copper-dependent formation of 8-hydroxy-2′-deoxyguanosine in DNA and induction of apoptotic cell death. Toxicol. Vitro, 18, 783-789.
62. Ying, L., Hofseth, L.J. (2007) An emerging role for endothelial nitric oxide synthase in chronic inflammation and cancer. Cancer Res., 67, 1407-1410.
63. Chin, K., Kurashima, Y., Ogura, T., Tajiri, H., Yoshida, S., Esumi, H. (1997) Induction of vascular endothelial growth factor by nitric oxide in human glioblastoma and hepatocellular carcinoma cells. Oncogene, 15, 437-442.
64. Singh, R. P., Agarwal, R. (2007) Inducible nitric oxide synthasevascular endothelial growth factor axis: A potential target to inhibit tumor angiogenesis by dietary agents. Curr. Cancer Drug Targets, 7, 475-483.
65. Landino, L. M., Crews, B. C., Timmons, M. D., Morrow, J. D., Marnett, L. J. (1996) Peroxynitrite, the coupling product of nitric oxide and superoxide, activates prostaglandin biosynthesis. Proc. Natl. Acad. Sci. USA, 93, 15069-15074.
66. Dairou, J., Atmane, N., Rodrigues-Lima, F., Dupret, J. M. (2004) Peroxynitrite irreversibly inactivates the human xenobioticmetabolizing enzyme arylamine N-acetyltransferase 1 (NAT1) in human breast cancer cells: A cellular and mechanistic study. J. Biol. Chem., 279, 7708-7714.
67. Huang, M. T., Lysz, T., Ferraro, T., Abidi, T. F., Laskin, J. D., Conney, A. H. (1991) Inhibitory effects of curcumin on in vitro lipoxygenase and cyclooxygenase activities in mouse epidermis. Cancer Res., 51, 813-819.
68. Qiao, L., Kozoni, V., Tsioulias, G. J., Koutsos, M. I., Hanif, R., Shiff, S. J. (1995) Selected eicosanoids increase the proliferation rate of human colon carcinoma cell lines and mouse colonocytes in vivo. Biochim. Biophys. Acta, 1258, 215-223.
69. Imler, J. L., Wasylyk, B. (1989) AP1, a composite transcription factor implicated in abnormal growth control. Prog. Growth Factor Res., 1, 69-77.
70. Dedieu, S., Lefebvre, P. (2006) Retinoids interfere with the AP1 signalling pathway in human breast cancer cells. Cell Signal, 18, 889-898.
71. Shishodia, S., Singh, T., Chaturvedi, M. M. (2007) Modulation of transcription factors by curcumin. Adv. Exp. Med. Biol., 595, 127-148.
72. Andela, V. B., Gordon, A. H., Zotalis, G., Rosier, R. N., Goater, J. J., Lewis, G. D., Schwarz, E. M., Puzas, J. E., O'Keefe, R. J. (2003) NFkappaB: A pivotal transcription factor in prostate cancer metastasis to bone. Clin. Orthop. Relat. Res., 415, S75-S85.
73. Tergaonkar, V. (2006) NFkappaB pathway: A good signaling paradigm and therapeutic target. Int. J. Biochem. Cell Biol., 38, 1647-1653.
74. Guadagni, F., Ferroni, P., Palmirotta, R., Portarena, I. Formica, V., Roselli, M. (2007) TNF/VEGF cross-talk in chronic inflammationrelated cancer initiation and progression: An early target in anticancer therapeutic strategy. In Vivo, 21, 147-161.
75. Mocellin, S., Nitti, D. (2008) TNF and cancer: The two sides of the coin. Front. Biosci., 13, 2774-2783.
76. Turkson, J. (2004) STAT proteins as novel targets for cancer drug discovery. Expert. Opin. Ther. Targets, 8, 409-422.
77. Blasius, R., Reuter, S., Henry, E., Dicato, M., Diederich, M. (2006) Curcumin regulates signal transducer and activator of transcription (STAT) expression in K562 cells. Biochem. Pharmacol., 72, 1547-1554.
78. Chen, W. H., Chen, Y., Cui, G. H., Gu, J. X., Hu, D., Chen, W. K., Li, X. G. (2004) Effect of curcumin on STAT5 signaling pathway in primary CML cells. Zhongguo Shi Yan Xue Ye Xue Za Zhi, 12, 572-576.
79. Chen, W. H., Chen, Y., Gu, J. X., He, J. (2004) Effect of curcumin on STAT5 signaling molecule in K562 cells. Zhonghua Xue Ye Xue Za Zhi, 25, 151-153.
80. Natarajan, C., Bright, J. J. (2002) Curcumin inhibits experimental allergic encephalomyelitis by blocking IL-12 signaling through Janus kinase-STAT pathway in T lymphocytes. J. Immunol., 168, 6506-6513.
81. Rajasingh, J., Raikwar, H. P., Muthian, G., Johnson, C., Bright, J. J. (2006) Curcumin induces growth-arrest and apoptosis in association with the inhibition of constitutively active JAK-STAT pathway in T cell leukemia. Biochem. Biophys. Res. Commun., 340, 359-368.
82. Jacob, A., Wu, R., Zhou, M., Wang, P. (2007) Mechanism of the anti-inflammatory effect of curcumin: PPAR-γ Activation. PPAR Res., 2007, 89369.
83. Chen, A., Xu, J. (2005) Activation of PPAR{gamma} by curcumin inhibits Moser cell growth and mediates suppression of gene expression of cyclin D1 and EGFR. Am. J. Physiol. Gastrointest. Liver Physiol., 288, G447-G456.
84. Song, G., Mao, Y. B., Cai, Q. F., Yao, L. M., Ouyang, G. L., Bao, S. D. (2005) Curcumin induces human HT-29 colon adenocarcinoma cell apoptosis by activating p53 and regulating apoptosisrelated protein expression. Braz. J. Med. Biol. Res., 38, 1791-1798.
85. Liu, E., Wu, J., Cao, W., Zhang, J., Liu, W., Jiang, X., Zhang, X. (2007) Curcumin induces G2/M cell cycle arrest in a p53-dependent manner and upregulates ING4 expression in human glioma. J. Neurooncol., 85, 263-270.
86. Gavert, N., Ben-Ze'ev, A. (2007) Beta-catenin signaling in biological control and cancer. J. Cell Biochem., 102, 820-828.
87. Takahashi-Yanaga, F., Sasaguri, T. (2007) The Wnt/β-catenin signaling pathway as a target in drug discovery. J. Pharmacol. Sci., 104, 293-302.
88. Tycko, B., Li, C. M., Buttyan, R. (2007) The Wnt/beta-catenin pathway in Wilms tumors and prostate cancers. Curr. Mol. Med., 7, 479-489.
89. Park, C. H., Hahm, E. R., Park, S., Kim, H. K., Yang, C. H. (2005) The inhibitory mechanism of curcumin and its derivative against beta-catenin/ Tcf signaling. FEBS Lett., 579, 2965-2971.
90. Jaiswal, A. S., Marlow, B. P., Gupta, N., Narayan, S. (2002) Betacatenin-mediated transactivation and cell-cell adhesion pathways are important in curcumin (diferuylmethane)-induced growth arrest and apoptosis in colon cancer cells. Oncogene, 21, 8414-8127.
91. Narayan, S. (2004) Curcumin, a multi-functional chemopreventive agent, blocks growth of colon cancer cells by targeting betacatenin-mediated transactivation and cell-cell adhesion pathways. J. Mol. Histol., 35, 301-307.
92. Ciolino, H. P., Daschner, P. J., Wang, T. T., Yeh, G. C. (1998) Effect of curcumin on the aryl hydrocarbon receptor and cytochrome P450 1A1 in MCF-7 human breast carcinoma cells. Biochem. Pharmacol., 56, 197-206.
93. Thapliyal, R., Deshpande, S. S., Maru, G. B. (2001) Effects of turmeric on the activities of benzo(a)pyrene-induced cytochrome P-450 isozymes. J. Environ. Pathol. Toxicol. Oncol., 20, 59-63.
94. Thapliyal, R., Maru, G. B. (2001) Inhibition of cytochrome P450 isozymes by curcumins in vitro and in vivo. Food Chem. Toxicol., 39, 541-547.
95. Bhandarkar, S. S., Arbiser, J. L. (2007) Curcumin as an inhibitor of angiogenesis. Adv. Exp. Med. Biol., 595, 185-195.
96. Chen, W. H., Chen, Y., Cui, G. H. (2005) Effects of TNF-alpha and curcumin on the expression of VEGF in Raji and U937 cells and on angiogenesis in ECV304 cells. Chin. Med. J. (Engl), 118, 2052-2057.
97. Gately, S., Li, W. W. (2004) Multiple roles of COX-2 in tumor angiogenesis: A target for antiangiogenic therapy. Semin. Oncol., 31, 2-11.
98. Arbiser, J. L., Klauber, N., Rohan, R., van Leeuwen, R., Huang, M. T., Fisher, C., Flynn, E., Byers, H. R. (1998) Curcumin is an in vivo inhibitor of angiogenesis. Mol. Med., 4, 376-383.
99. Rundhaug, J. E. (2005) Matrix metalloproteinases and angiogenesis. J. Cell. Mol. Med., 9, 267-285.
100. Smith, P. C., Santibañez, J. F., Morales, J. P., Martinez, J. (2004) Epidermal growth factor stimulates urokinase-type plasminogen activator expression in human gingival fibroblasts. Possible modulation by genistein and curcumin. J. Periodontal. Res., 39, 380-387.
101. Mitra, A., Chakrabarti, J., Banerji, A., Chatterjee, A., Das, B. R. (2006) Curcumin, a potential inhibitor of MMP-2 in human laryngeal squamous carcinoma cells HEp2. J. Environ. Pathol. Toxicol. Oncol., 25, 679-690.
102. Saja, K., Babu, M. S., Karunagaran, D., Sudhakaran, P. R. (2007) Anti-inflammatory effect of curcumin involves downregulation of MMP-9 in blood mononuclear cells. Int. Immunopharmacol., 7, 1659-1667.
103. Shankar, S., Ganapathy, S., Chen, Q., Srivastava, R. K. (2008) Curcumin sensitizes TRAIL-resistant xenografts: Molecular mechanisms of apoptosis, metastasis and angiogenesis. Mol. Cancer, 7, 16.
104. Ray, S., Chattopadhyay, N., Mitra, A., Siddiqi, M., Chatterjee, A. (2003) Curcumin exhibits antimetastatic properties by modulating integrin receptors, collagenase activity, and expression of Nm23 and E-cadherin. J. Environ. Pathol. Toxicol. Oncol., 22, 49-58.
105. Banerji, A., Chakrabarti, J., Mitra, A., Chatterjee, A. (2004) Effect of curcumin on gelatinase A (MMP-2) activity in B16F10 melanoma cells. Cancer Lett., 211, 235-242.
106. Kumar, A., Dhawan, S., Hardegen, N. J., Aggarwal, B. B. (1998) Curcumin (Diferuloylmethane) inhibition of tumor necrosis factor (TNF)-mediated adhesion of monocytes to endothelial cells by suppression of cell surface expression of adhesion molecules and of nuclear factor-kB activation. Biochem. Pharmacol., 55, 775-783.
107. Fuller, B., Dijk, S., Butler, P., Hoang, V., Davidson, B. (2003) Proinflammatory agents accumulate during donor liver cold preservation: a study on increased adhesion molecule expression and abrogation by curcumin in cultured endothelial cells. Cryobiology, 46, 284-288.
108. Karunagaran, D., Rashmi, R., Kumar, T. R. (2005) Induction of apoptosis by curcumin and its implications for cancer therapy. Curr. Cancer Drug. Targets, 5, 117-129.
109. Mackenzie, G. G., Queisser, N., Wolfson, M. L., Fraga, C. G. Adamo, A. M. Oteiza, P. I. (2008) Curcumin induces cell-arrest and apoptosis in association with the inhibition of constitutively active NF-kappaB and STAT3 pathways in Hodgkin's lymphoma cells. Int. J. Cancer, 123, 56-65.
110. Khar, A., Ali, A. M., Pardhasaradhi, B. V., Varalakshmi, C., Anjum, R., Kumari, A. L. (2001) Induction of stress response renders human tumor cell lines resistant to curcumin-mediated apoptosis: Role of reactive oxygen intermediates. Cell Stress Chaperones, 6, 368-376.
111. Woo, J. H., Kim, Y. H., Choi, Y. J., Kim, D. G., Lee, K. S., Bae, J. H., Min, D. S., Chang, J. S., Jeong, Y. J. Lee, Y. H., Park, J. W., Kwon, T. K. (2003) Molecular mechanisms of curcumin-induced cytotoxicity: induction of apoptosis through generation of reactive oxygen species, down-regulation of Bcl-XL and IAP, the release of cytochrome c and inhibition of Akt. Carcinogenesis, 24, 1199-1208.
112. Liu, B., Bai, Q. X., Chen, X. Q., Gao, G. X., Gu, H. T. (2007) Effect of curcumin on expression of survivin, Bcl-2 and Bax in human multiple myeloma cell line. Zhongguo Shi Yan Xue Ye Xue Za Zhi, 15, 762-766.
113. Cui, S. X., Qu, X. J., Xie, Y. Y., Zhou, L., Nakata, M., Makuuchi, M., Tang, W. (2006) Curcumin inhibits telomerase activity in human cancer cell lines. Int. J. Mol. Med., 18, 227-231.
114. Aggarwal, B. B., Banerjee, S., Bharadwaj, U., Sung, B., Shishodia, S., Sethi, G. (2007) Curcumin induces the degradation of cyclin E expression through ubiquitin-dependent pathway and up-regulates cyclin-dependent kinase inhibitors p21 and p27 in multiple human tumor cell lines. Biochem. Pharmacol., 73, 1024-1032.
115. Kuttan, G., Kumar, K. B., Guruvayoorappan, C., Kuttan, R. (2007) Antitumor, anti-invasion, and antimetastatic effects of curcumin. Adv. Exp. Med. Biol., 595, 173-184.
116. Scott, D. W., Loo, G. (2007) Curcumin-induced GADD153 upregulation: modulation by glutathione. J. Cell Biochem., 101, 307-320.
117. Aggarwal, B. B., Shishodia, S., Takada, Y., Banerjee, S., Newman, R. A., Bueso-Ramos, C. E., Price, J. E. (2005) Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice. Clin. Cancer Res., 11, 7490-7498.
118. Bava, S. V., Puliappadamba, V. T., Deepti, A., Nair, A., Karunagaran, D., Anto, R. J. (2005) Sensitization of taxol-induced apoptosis by curcumin involves down-regulation of nuclear factorkappaB and the serine/ threonine kinase Akt and is independent of tubulin polymerization. J. Biol. Chem., 280, 6301-6308.
119. Chendil, D., Ranga, R. S., Meigooni, D., Sathishkumar, S., Ahmed, M. M. (2004) Curcumin confers radiosensitizing effect in prostate cancer cell line PC-3. Oncogene, 23, 1599-1607.
120. Choi, B. H., Kim, C. G., Lim, Y., Shin, S. Y., Lee, Y. H. (2008) Curcumin down-regulates the multidrug-resistance mdr1b gene by inhibiting the PI3K/Akt/NF kappa B pathway. Cancer Lett., 259, 111-118.
121. Tang, X. Q., Bi, H., Feng, J. Q., Cao, J. G. (2005) Effect of curcumin on multidrug resistance in resistant human gastric carcinoma cell line SGC7901/VCR. Acta Pharmacol. Sin., 26, 1009-1016.
122. Chearwae, W., Shukla, S., Limtrakul, P., Ambudkar, S. V. (2006) Modulation of the function of the multidrug resistance-linked ATPbinding cassette transporter ABCG2 by the cancer chemopreventive agent curcumin. Mol. Cancer Ther., 5, 1995-2006.
123. Limtrakul, P., Chearwae, W., Shukla, S., Phisalphong, C., Ambudkar, S. V. (2007) Modulation of function of three ABC drug transporters, P-glycoprotein (ABCB1), mitoxantrone resistance protein (ABCG2) and multidrug resistance protein 1 (ABCC1) by tetrahydrocurcumin, a major metabolite of curcumin. Mol. Cell Biochem., 296, 85-95.
124. Salmaso, S., Bersani, S., Semenzato, A., Caliceti, P. (2007) New cyclodextrin bioconjugates for active tumour targeting. J. Drug Target, 15, 379-390.